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Abstract
The genetic make-up of the host has a major influence on its response to combat pathogens. For influenza A virus, several
single gene mutations have been described which contribute to survival, the immune response and clearance of the
pathogen by the host organism. Here, we have studied the influence of the genetic background to influenza A H1N1 (PR8)
and H7N7 (SC35M) viruses. The seven inbred laboratory strains of mice analyzed exhibited different weight loss kinetics and
survival rates after infection with PR8. Two strains in particular, DBA/2J and A/J, showed very high susceptibility to viral
infections compared to all other strains. The LD50 to the influenza virus PR8 in DBA/2J mice was more than 1000-fold lower
than in C57BL/6J mice. High susceptibility in DBA/2J mice was also observed after infection with influenza strain SC35M. In
addition, infected DBA/2J mice showed a higher viral load in their lungs, elevated expression of cytokines and chemokines,
and a more severe and extended lung pathology compared to infected C57BL/6J mice. These findings indicate a major
contribution of the genetic background of the host to influenza A virus infections. The overall response in highly susceptible
DBA/2J mice resembled the pathology described for infections with the highly virulent influenza H1N1-1918 and newly
emerged H5N1 viruses.
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Introduction
Influenza A virus infections have caused multiple severe
pandemics in recent human history. It is estimated that during
the 1918 ‘‘Spanish flu’’ pandemics, about 50 million people died
world-wide [1], and during the pandemics of 1957 and 1968,
about 1 million people succumbed to influenza [2,3]. Seasonal
yearly epidemics are caused by variants of the subtypes H1N1 and
H3N2 and kill about 1 million people per year world-wide [4].
Recently, a new subtype, H5N1, appeared which is highly
pathogenic in birds and can be transmitted to humans that are
in close contact with infected birds. H5N1 infections in humans
cause a severe pneumonia that is fatal in about 50% of infected
individuals [5,6].
Intensive research has been performed on the virulence and
evolution of the influenza virus [7,8]. However, very little is known
about the influence of specific genes or genetic backgrounds in
humans that contribute to the susceptibility or resistance to
influenza infections. The importance of host genetic factors in
humans has been shown for several bacterial and viral pathogens
[9–11]. An investigation of the influenza death records over the
past 100 years in the population of Utah provided evidence for an
increased risk in close and distant related relatives [12], although
the analysis of influenza related deaths in the population of Iceland
during the Spanish flu pandemic did not find any conclusive
evidence for a genetic contribution [13]. It is important to note
that it is very difficult to perform studies on host susceptibility to
acute infections in humans due to the complexity of genetic
variants and largely different environmental influences, such as
nutrition, life style, medication, exposure to other pathogens, etc.
Thus, a much better way to understand the principle mechanisms
underlying susceptibility or resistance to infectious diseases is to
use experimental animal model systems.
The mouse has been shown to represent a particularly useful
model to study the virulence of the highly pathogenic H5N1 and
the 1918 H1N1 influenza viruses [14,15]. For less virulent virus
subtypes, depletion of specific immune cell populations has
demonstrated critical involvements of neutrophils [16,17], macro-
phages [17,18], dendritic cells [19,20], natural killer cells [21], B
cells [22], and T killer cells [23] during the host response.
Using mouse mutant strains, several mammalian genes have
been shown to be important for the host defense against an
influenza virus infection, that include the Mx1, Stat1, Pkr, Ifnar1,
and Ncr1 genes [21,24–26]. However, it is obvious that this is only a
very small fraction of the essential genes involved. A study
performed by Crozat et al. in 2006 [27] estimates that about 480
genes are critical for the host defense against an infection with
mouse cytomegalovirus, and more than 1000 genes changed their
expression levels after infection with Mycobacterium tuberculosis [28]
or influenza A virus [29].
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host response is not only influenced by single genes but by
combinations of genes and their variants. Thus, besides Mendelian
(single) genes, also complex (multi-gene) genetic effects need to be
analyzed to understand the full repertoire of host responses to
pathogens. For mice, well defined genetic reference populations
(GRP) exist that allow the analysis of complex genetic traits and the
effect of multiple contributing gene loci. Mouse GRP are available
as inbred laboratory and wild-derived mouse strains, recombinant
inbred strains, interspecific recombinant inbred strains, chromo-
some substitution strains, and consomic strains [30]. These
resources have been extensively used to identify quantitative traits
and single gene loci contributing to the host response to infections
with different pathogens (reviewed in e.g., [31–37]). However, in
most studies with influenza virus, only two strains of mice, BALB/c
and C57BL/6, have been used, but have not been compared
directly.Todateonlyonestudyhasmade adirectcomparisonofthe
influence of genetic background on gene expression and suscepti-
bility in BALB/cByJ versus C57BL/6J mice [29].
As a first step towards the analysis of complex genetic traits
influencing resistance and susceptibility to influenza, we have
investigated the host response to two virus subtypes in seven inbred
laboratory mouse strains. Two mouse strains were identified which
exhibited a very pronounced susceptibility to influenza infections.
We then compared weight loss, survival, lung pathologies,
cytokine/chemokine responses and virus replication between one
of the highly susceptible strains, DBA/2J, and one of the more
resistant strains, C57BL/6J. Whereas C57BL/6J mice could
control virus replication and clear the infection, DBA/2J mice
exhibited higher viral loads, higher levels of cytokines and
chemokines, enhanced lung pathology, and were not able to clear
the viral infection.
Results
Inbred mouse strains exhibit large differences in their
response to influenza A virus
Seven different inbred laboratory mouse strains were infected
with a dose of 2610
3 FFU of influenza A virus PR8 (H1N1) and
followed for a period of 14 days after infection. As illustrated in
figure 1, large differences in the kinetics of weight loss and survival
were observed. Most notably, mice from two inbred strains, DBA/
2J and A/J, lost weight very rapidly and died within the first seven
days after infection, or were sacrificed because weight loss
exceeded 25%. All infected mice from the other strains survived
this infection dose. The weight loss in the highly susceptible strains
DBA/2J and A/J mouse strains was significantly different
compared to all resistant strains (table 1). The surviving strains
exhibited three principle types of weight loss kinetics. BALB/cByJ,
CBA/J and SJL/JOrlCrl rapidly lost weight within the first days
after infection until about day 6 to 7 and then slowly recovered,
with SJL/JOrlCrl being the least affected in this group (figure 1).
C57BL/6J mice did not lose weight early after infection but
rapidly lost weight after day 4 until day 7 and then quickly
recovered (figure 1). The weight loss in C57BL/6J mice was
significantly different to the BALB/c mouse strain on days 2–4 but
not at later time points (table 1). FVB/NJ mice were the least
affected by this infection dose (figure 1, table 1). The weight
change in infected DBA/2J and C57BL/6J mice was significantly
different compared to mock-infected mice, instilled with PBS only
(data not shown).
LD50 and course of infection are very different between
C57BL/6J and DBA/2J mouse strains
Hybrid mice, (C57BL/6J6DBA/2J) F1, showed an intermedi-
ate phenotype with a rapid weight loss within the first days after
infection (figure 2). However, this weight loss was not as dramatic
as for DBA/2J. It reached its peak on day 7, similar to the kinetics
observed for C57BL/6J mice. After day 7, F1 hybrid mice
recovered and weight gain was slightly delayed, compared to
C57BL/6J mice.
The DBA/2J sub-strain is deficient in a specific subset of natural
killer cells [38]. Therefore, another sub-strain of DBA, DBA/
2NHsd, was studied which is able to generate this subset of NK
cells. As shown in figure 2, the DBA/2NHsd sub-strain was as
susceptible as DBA/2J. Thus, the high susceptibility in DBA mice
is not due to this unique feature of the DBA/2J sub-strain.
To further investigate the host response between susceptible and
resistant mouse strains, we selected one of the highly susceptible
strains, DBA/2J, and one of the resistant strains, C57BL/6J for
study in more detail.
Figure 1. Different inbred laboratory mouse strains exhibit variable kinetics of weight loss and survival after infection with
Influenza A virus. C57BL/6J, DBA/2J, FVB/NJ, CBA/J, BALB/cByJ, A/J and SJL/JOrlCrl mice were infected intra-nasally with 2610
3 FFU of PR8 virus.
Weight loss and survival of infected mice was followed over a period of 14 days. Mortality also includes mice that were sacrificed because they had
lost more than 25% of body weight. Mean percent of body weight change (6SEM) for each group of inbred strains is shown. For DBA/2J and C57BL/
6J mice, data are from two independent experiments. Statistical analysis of pair wise comparisons for all strains and days are presented in table 1.
doi:10.1371/journal.pone.0004857.g001
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DAY 2 C57BL/6J DBA/2J A/J BALB/cByJ FVB/NJ CBA/J SJL/JOrlCrl
C57BL/6J * n.s *** n.s * n.s
DBA/2J * n.s n.s n.s n.s
A/J *** n.s * *
BALB/cByJ ** n.s n.s
FVB/NJ *n . s
CBA/J n.s
SJL/JOrlCrl
DAY 3 C57BL/6J *** *** *** n.s ** **
DBA/2J * n.s ** n.s n.s
A/J ** *** * **
BALB/cByJ ** n.s n.s
FVB/NJ **
CBA/J n.s
SJL/JOrlCrl
DAY 4 C57BL/6J *** *** * n.s n.s n.s
DBA/2J n.s *** *** *** ***
A/J *** *** *** ***
BALB/cByJ *** n.s n.s
FVB/NJ n.s *
CBA/J n.s
SJL/JOrlCrl
DAY 5 C57BL/6J *** *** n.s. n.s n.s n.s
DBA/2J n.s *** *** *** ***
A/J *** *** *** ***
BALB/cByJ ** n.s n.s
FVB/NJ n.s **
CBA/J n.s
SJL/JOrlCrl
DAY 6 C57BL/6J ** *** n.s. ** n.s n.s
DBA/2J n.s *** *** *** ***
A/J *** *** *** ***
BALB/cByJ ** n.s n.s
FVB/NJ **
CBA/J n.s
SJL/JOrlCrl
DAY 7 C57BL/6J *** *** * *** n.s n.s
DBA/2J n.d *** *** *** ***
A/J *** *** *** **
BALB/cByJ * n.s n.s
FVB/NJ **
CBA/J n.s
SJL/JOrlCrl
DAY 10 C57BL/6J * n.s ** n.s
BALB/cByJ ** n.s *
FVB/NJ *** n.s
CBA/J **
SJL/JOrlCrl
Influenza Host Susceptibility
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and DBA/2J mice to determine the relative range of susceptibility.
As shown in figure 3, DBA/2J mice died at very low viral doses
(LD50 of 36 FFU) whereas all C57BL/6J mice survived doses of up
to 10
3 FFU. In this particular experiment, half of the C57BL/6J
mice died at an FFU of 2610
5. However, as mice had to be
sacrificed as part of the protocol when the weight loss was more
than 25%, the threshold for the lethal dose varied in C57BL/6J
mice. In other experiments with doses of 2610
5 FFU, C57BL/6J
mice lost weight close to 25% but did not exceed this threshold
and were recorded as survivors. Therefore, we conclude that the
LD50 for C57BL/6J is above or equal to 2610
5 FFU. It thus
exceeds the LD50 for DBA/2J mice by at least a factor of 10
3.
For infectious diseases, differences between sexes are observed
in several cases. We therefore compared the susceptibility to
influenza infections in male and female mice. As illustrated in
figure 4, male and female mice from the DBA/2J strain showed
similar weight loss kinetics and were both highly susceptible. Both
male and female mice from the C57BL/6J strain were resistant.
Slight differences in the weight loss curves were observed between
DAY 2 C57BL/6J DBA/2J A/J BALB/cByJ FVB/NJ CBA/J SJL/JOrlCrl
DAY 14 C57BL/6J ** n.s ** n.s
BALB/cByJ ** n.s *
FVB/NJ ** n.s
CBA/J **
SJL/JOrlCrl
p-values for significance were calculated for all pair wise comparisons between strains and for all days shown in figure 1 using non-parametric Mann-Whitney-U-test.
Day 3: the susceptible strain DBA/2J showed significant differences in weight loss compared to the resistant strains C57BL/6J (p,0.001) and FVB (p,0.01); the
susceptible strain A/J showed significant weight loss compared to all resistant strains (BALB/c: p,0.01; FVB: p,0.001; CBA: p,0.05; SJL: p,0.01). Days 4, 5, 6, 7: the
susceptible strains DBA/2J and A/J showed significant differences in weight loss compared to all resistant strains (in almost all cases with p,0,001; except for day 6
between DBA/2J and C57BL/6J: p,0.01). Strain C57BL/6J exhibited significant differences in weight loss compared to the BALB/c mouse strain at days 2–4 (p,0.001 at
days 2 and 3, p,0.05 at day 4) but not at later time points. On days 6 and 7, FVB differed significantly from all other strains (p-values from ,0.05 to ,0.001).
*p value,0.05.
**p,0.01.
***p value,0.001.
doi:10.1371/journal.pone.0004857.t001
Table 1. cont.
Figure 2. (C57BL/6J6DBA/2J) F1 mice display an intermediate phenotype after infection with Influenza A virus and DBA/2NHsd
exhibit the same susceptibility as DBA/2J. C57BL/6J, DBA/2J, DBA/2NHsd and (C57BL/6J6DBA/2J) F1 (labeled B6D2F1 in the figure) mice were
infected intra-nasally with 2610
3 FFU PR8 virus. Weight loss and survival of infected mice was followed over a period of 14 days. Mortality also
includes mice that were sacrificed because they had lost more than 25% of body weight. Mean percent of body weight change (6SEM) are shown.
For DBA/2J, C57BL/6J, and B6D2F1, data from two independent experiments were combined. p-values for significance were calculated for pair wise
comparisons between all strains and for all days using non-parametric Mann-Whitney-U-test. The (C57BL/6J6DBA/2J) F1 group differed significantly
in weight loss from days 2–4 when compared to the C57BL/6J group (p,0.001 on days 2, 3; p,0.01 on day 4) and from days 3–5 when compared to
the DBA/2J and DBA/2NHsd groups (p,0.01). On days 2–5, DBA/2J and DBA/2NHsd strains differed significantly in their weight loss from C57BL/6J
(p,0.001 for all cases, except p,0.01 at day 5 for DBA/2NHsd vs. C57BL/6J). Weight loss was not significantly different between the sub-strains DBA/
2J and DBA/2NHsd groups for all days.
doi:10.1371/journal.pone.0004857.g002
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for the C57BL/6J groups. For DBA/2J mice significant differences
were observed at days 2–4 after infection.
The PR8 (H1N1) influenza A virus was initially isolated from a
human and subsequently adapted to mice [39]. To exclude that
the observed mouse strain differences are specific for only one
influenza subtype, we infected C57BL/6J and DBA/2J mice with
another mouse-adapted virus subtype, SC35M. This virus
represents an H7N7 influenza A virus subtype, was originally
isolated from seal and then adapted to mouse [40]. After intra-
nasal infection with SC35M virus, DBA/2J mice exhibited the
same high susceptibility (figure 5A) as observed after infection with
the PR8 virus, and C57BL/6J mice were much more resistant
than DBA/2J mice. However, compared to infections with PR8
(figures 1 and 3), C57BL/6J mice started to die at lower doses of
infection with SC35M and exhibited a slightly different weight loss
kinetics (figure 5C). The peak weight loss was still observed
between days 7 and 8. But in contrast to infections with PR8,
infection of C57BL/6J mice with SC35M resulted in an early
weight loss during the first three days, although at this infection
dose, none of the C57BL/6J mice died. The C57BL/6J mice then
transiently recovered and lost weight again with a kinetics similar
to the weight loss observed for PR8 infections.
Early differences in viral loads are present between
C57BL/6J and DBA/2J mouse strains
The extreme susceptibility of DBA/2J mice could be due to
enhanced viral replication and associated tissue damage or a
detrimental immunopathology of the host response, or both.
Therefore, we analyzed viral loads by determining infectious
particles and viral mRNA copies of the hemagglutinin (HA) gene
in the lung. On days 1 and 2, the amount of infectious virus
particles was about 100- and 80-fold higher in DBA/2J mice
compared to C57BL/6J mice (figure 6A). This difference
decreased to about 20 and 10-fold on days 3 and 4, respectively
(figure 6A). In the surviving C57BL/6J mice, virus titers were
below the level of detection at day 8 (figure 6A). Similarly, viral
HA mRNA was between 5- and 9-fold higher in DBA/2J mice
compared to C57BL/6J mice at days 1–3 and at day 6 (figure 6B).
At day 4 after infection, this difference was less pronounced (2.6-
Figure 3. DBA/2J mice are highly susceptible to PR8 infections compared to C57BL/6J mice. DBA/2J (A) and C57BL/6J (B) mice were
infected with increasing doses of PR8 virus via the intranasal route and survival was recorded for the following 14 days. Mortality includes also mice
that were sacrificed because they had lost more than 25% of body weight.
doi:10.1371/journal.pone.0004857.g003
Figure 4. Male and female mice of DBA/2J and C57BL/6J mice show similar weight loss and survival after infection with Influenza A
virus. DBA/2J female, DBA/2J male, C57BL/6J female and C57BL/J male were infected intra-nasally with 2610
3 FFU PR8 virus. Weight loss and survival
of infected mice was followed over a period of 14 days. Mortality includes also mice that were sacrificed because they had lost more than 25% of
body weight. Mean percent of body weight change (6SEM) is shown. p-values for significance were calculated for pair wise comparison between all
groups and for all days using non-parametric Mann-Whitney-U-test. On days 2–4, all DBA/2J male and female groups differed significantly in their
weight loss from the C57BL/6J groups (p,0.001 for all comparisons). No consistently significant difference was observed between male and female
C57BL/6J groups (except at day 4, p,0.05), whereas the male and female DBA/2J groups were significantly different at days 2–4 (p,0.05 at day 2 and
p,0.01 at days 3, 4).
doi:10.1371/journal.pone.0004857.g004
Influenza Host Susceptibility
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days 4 and 6 was most probably due to the severe pathology in the
lungs of these mice (see also histological studies) resulting in
epithelial cell necrosis which does not allow any further increase in
virus replication. In C57BL/6J mice, copy numbers of viral HA
RNA decreased considerably after day 6 and were below the level
of detection on day 14 (figure 6B).
Expression of inflammatory cytokines is higher in DBA/2J
mice
During the course of an infection, the host responds with the
production of various cytokines and chemokines which then
activate the different components of the innate and adaptive
immune system. Therefore, the presence of several cytokines and
chemokines was studied in broncho-alveolar lavages (BAL) of
infected C57BL/6J and DBA/2J mice. In total, 22 cytokines and
chemokines were analyzed. As shown in figure 7A, the cytokines
Il5, Il6, Il1a, Il12, and Csf3 (G-CSF) were elevated in the lungs of
infected compared to non-infected mice. In all cases, levels of
expression were higher in DBA/2J than in C57BL/6J mice.
Similarly, the chemokines Ccl2 (MCP-1), Ccl3 (MIP-1a), Ccl5
(RANTES), Cxcl1 (KC), Cxcl2 (MIP-2), Cxcl9 (MIG), and Cxcl10
(IP-10) were higher in infected, compared to non-infected DBA/2J
and C57BL/6J mice (figure 7B). DBA/2J mice exhibited a higher
level of expression for all chemokines tested. Also, at the
transcriptional level, elevated expression of chemokines and
cytokines in DBA/2J compared to C57BL/6J mice was observed
by real-time PCR analysis for Ccl2, Ccl3, Cxcl10 and Il6 (figure 7C).
Severe damage of bronchial epithelia occurs in DBA/2J
mice
Histological analyses of infected mice revealed striking differences
between the tissue lesions in DBA/2J and C57BL/6J mice. The
overall lung tissues were more densely consolidated with larger
numbers of affected airways in DBA/2J mice compared to C57BL/
6J mice (figure 8A, B). In both mouse strains, bronchial and
bronchiolar epithelial cells showed degeneration, necrosis and loss
with accumulation of sloughed cells and mostly degenerate
neutrophils in the airway lumen at days 2 and 3 after infection.
However, the degree of bronchial epithelial necrosis and airway
Figure 5. DBA/2J mice are highly susceptible to H7N7 (SC35M) virus infection compared to C57BL/6J mice. (A): DBA/2J and C57BL/6J
mice were infected intra-nasally with 2610
3 FFU SC35M virus. DBA/2J (B) and C57BL/6J (C) mice were infected with increasing doses of SC35M (H7N7)
virus via the intra-nasal route. Weight loss and survival of infected mice was followed over a period of 14 days. Mortality includes also mice that were
sacrificed because they had lost more than 25% of body weight. Data are from two independent experiments. Mean percent of body weight change
(6SEM) is shown. DBA/2J and C57BL/6J groups were compared for statistically significant differences using non-parametric Mann-Whitney-U-test. *: p
value,0.05; **: p,0.01; ***: p value,0.001.
doi:10.1371/journal.pone.0004857.g005
Figure 6. Higher viral load is detected in DBA/2J mice compared to C57BL/6J mice. DBA/2J and C57BL/6J mice were infected intra-nasally
with 2610
3 FFU and viral load was determined at the indicated times post inoculation for infectious particles measured by foci assay (A) or by copy
number of viral hemagglutinin (HA) RNA (B). Mean +/2 SEM are shown. For foci assay in (A), 9 DBA/2J mice were used at all time points, and for
C57BL/6J, 6 mice were used at day1, 8 mice at day 2 and 9 mice at days 3, 4, and 8. For RNA assays in (B), 10 mice were used except 15 for day 4, and 5
for day 6. DBA/2J and C57BL/6J mice were compared for statistical significant differences using non-parametric Mann-Whitney-U-test. *: p
value,0.05; **: p,0.01; ***: p value,0.001.
doi:10.1371/journal.pone.0004857.g006
Influenza Host Susceptibility
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than C57BL/6J mice. This was accompanied by larger numbers of
neutrophilsand macrophages around the affected airways in DBA/2J
mice (figure8C,D).On the other hand, C57BL/6J mice developed a
much stronger perivascular and peribronchial infiltration of lympho-
cytes at day 4 after infection (figure 8E, F). Alveolar epithelial cells
were mostly unaffected. Few macrophages and virtually no plasma
cells were seen in the lungs, with no differences between the two
m o u s es t r a i n sa td a y s2t o4p o s ti n f e c t i o n .
Discussion
Studies in mouse model systems have revealed that hundreds of
genes are involved in the host defense against microbial infections
Figure 7. DBA/2J mice exhibit a stronger inflammatory response than C57BL/6J mice. DBA/2J (checked bars) and C57BL/6J mice (black
bars) were infected intra-nasally with 2610
3 FFU of PR8 virus. Bronchio-alveolar lavage (BAL) was collected from non-infected controls (c) or at the
indicated days (d1, d2, d3, d4) post infection, and the concentration of cytokines (A) or chemokines (B) was determined. Expression of cytokines and
chemokines was determined by real-time PCR (C). Each time point represents the mean value 6SEM of 7 mice per group for (A) and (B), and of 10
mice per group for (C). DBA/2J and C57BL/6J mice were compared for statistically significant differences using non-parametric Mann-Whitney-U-test.
*: p value,0.05; **: p,0.01; ***: p value,0.001.
doi:10.1371/journal.pone.0004857.g007
Figure 8. Severe damage of bronchial epithelia occurs in DBA/2J compared to C57BL/6J mice. DBA/2J (A, C, E) and C57BL/6J mice (B, D,
F) were infected intra-nasally with 2610
3 FFU of PR8 virus. Lung sections were stained with hematoxylin and eosin. A, B: Two days after infection, the
lungs of DBA/2J mice (A) were more consolidated with higher numbers of plugged airways (arrows) than C57BL/6J mice (B). C, D: The bronchioli and
bronchi of DBA/2J mice (C) were plugged with degenerate bronchial epithelial cells and neutrophils with higher degrees of degeneration, necrosis
and loss of epithelial cells (arrows) two days after infection. In addition, the airways were surrounded by larger numbers of neutrophils and
macrophages (asterisks). Airways of C57BL/6J mice (D) showed less damage with little or no plugging of airways. At that time point, the lungs of both
strains had few infiltrations with lymphocytes. E, F: Four days after infection, virtually no extravasations of lymphocytes were detected in DBA/2J mice
(E) whereas marked perivascular lymphocytic infiltrations (arrows) were observed in the pulmonary interstitium of C57BL/6J mice (F). Bars = 250 mm
(A, B), 25 mm (C, D) and 50 mm (E, F).
doi:10.1371/journal.pone.0004857.g008
Influenza Host Susceptibility
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complex [27,31–37]. Although several single gene mutations are
known which confer resistance or susceptibility to an infection with
influenza A virus, very few studies have addressed the influence of
multiple complex genetic interactions in mouse genetic reference
populations [29,41]. Therefore, as a first step towards the
understanding of complex genetic traits involved in the host
response to influenza infections, we have studied the susceptibility
to infection with H1N1 and H7N7 influenza virus subtypes in
different inbred laboratory mouse strains.
Our studies reveal that inbred mouse strains exhibit large
differences in their host response to an infection with the H1N1
influenza A virus (PR8). Both the time course of the weight loss as
well as survival rate was strikingly different between different
laboratory mouse strains. These results demonstrate a strong
genetic influence on the host susceptibility to influenza virus
infections. We hypothesize that the different kinetics of the weight
loss curves indicate that different mouse strains mount different
qualitative, quantitative and temporal profiles of the host defense.
For example, C57BL/6J mice were mostly affected at the point
which correlates with the activity of TRAIL-expressing influenza-
specific CD8 T cells infiltrating the infected lungs [42]. On the
other hand, BALB/cByJ, CBA/J and SJL/JOrlCrl mouse strains
showed weight loss early after infection, at a time when the peak of
virus replication in the respiratory epithelium is observed.
Most notably, two mouse strains, DBA/2J and A/J, exhibit an
extremely high susceptibility to influenza infections. All infected
animals died within the first seven days after inoculation with low
virus doses. The other strains tested showed 100% survival under
these conditions. The LD50 for the highly susceptible mouse strain
DBA/2J was more than three orders of magnitude lower
compared to the resistant strain C57BL/6J. DBA/2J mice were
highly susceptible to both the H1N1 (PR8) and H7N7 influenza
virus (SC35M) subtypes. Thus, DBA/2J mice seem to exhibit a
general high susceptibility to influenza virus infections, indepen-
dent of the virus subtype.
To our knowledge, this is the first study that directly compares
different inbred mouse laboratory strains for their susceptibility to
influenza A virus. Most laboratories have used BALB/c mice or, in
the context of knock-out mutants, C57BL/6J mice. So far, direct
comparisons of the susceptibility of inbred strains were only
performed for BALB/cByJ and C57BL/6J [29]. The analysis of
gene expression patterns in this previous study revealed that more
than 1000 genes were differentially expressed after infection with
influenza virus A/HKX31 (H3N2).
DBA/2J mice were also used in comparison to other inbred
mouse strains with regard to their susceptibility to infections with
other pathogens. After infection with group A streptococci, DBA/
2J belonged to the group of resistant mice [43,44], whereas after
infection with Mycobacterium tuberculosis, these mice were amongst
the susceptible strains [45,46]. Thus, DBA/2J mice do not appear
to suffer from a general immune deficiency.
We performed a more detailed comparison between a
susceptible strain, DBA/2J and a resistant strain, C57BL/6J, to
gain further insight into the cellular and molecular factors that
may contribute to the high susceptibility of DBA/2J mice to
influenza infection. In infected DBA/2J mice, we observed higher
virus replication at early time points after infection and a much
stronger immune response than in C57BL/6J infected mice.
Histological analyses showed that at day 4 after infection, the
damage of the bronchial epithelium was being repaired in
C57BL/6J mice but DBA/2J mice still showed the same severe
lung phenotype as on day 2. Thus, the most likely explanation for
the high susceptibility in DBA/2J mice is that both the continuous
high level of viral replication and associated destruction of the lung
epithelium as well as a highly activated and detrimental immune
response lead to the lethal outcome of the infection. Several studies
have demonstrated that both these factors can contribute to
influenza induced lung pathology [5].
At present, we do not have an explanation for the rapid
accumulation of virus at early time points after infection in DBA/
2J mice. This effect may be due to a high replication rate in
epithelial cells as it has been shown for a highly virulent PR8
variant [47]. Alternatively, receptors for virus entry into epithelial
cells may be more densely distributed or exhibit a more favorable
structure in DBA/2J mice. We have initiated studies to investigate
in more detail the spatial distribution and individual cellular viral
loads of infected cells in the lungs, as well as comparing the rate of
replication in mouse embryonic fibroblasts.
The analysis of broncho-alveloar fluid and transcripts in the
lung revealed that many cytokines and chemokines were expressed
in both C57BL/6J and DBA/2J mice after infection. Thus, DBA/
2J mice were able to mount a normal, early immune defense.
However, susceptible DBA/2J mice exhibited a much stronger
inflammatory response than resistant C57BL/6J mice. The CXC-
chemokines Cxcl1, Cxcl2, Cxcl9 and Cxcl10 were found to be
secreted into the broncho-alveolar space at a higher level in DBA/
2J than in C57BL/6J mice. Cxcl9 and Cxcl10 chemokines target
the Cxcr3 receptor expressed on activated T cells, whereas the
Cxcl2 chemokine targets the Cxcr2 receptor expressed on
neutrophils [48]. Of the CC chemokines, Ccl2, Ccl3 and Ccl5
were found to be elevated in DBA/2J mice. Both chemokines
target receptors on macrophages, T cells, NK cells, granulocytes
and dendritic cells [49]. Similarly, the cytokines Il1a, Il5, Il6, and
Il12 were secreted into the broncho-alveolar space of both strains
after infection but were higher in DBA/2J mice. The inflamma-
tory protein Tnfa was found consistently, although at a low level in
DBA/2J but not in C57BL/6J mice (data not shown). The
production of cytokines and chemokines as a response to influenza
A infection in mice and humans has been described in various
studies (e.g. [5,50,51]) and it has been postulated that a strong
innate immune response may cause severe detrimental immune
pathologies [5]. Therefore, these observations indicate that the
strong early inflammatory response contributes to the severe lung
pathology and lethality in DBA/2J mice.
The strongly elevated inflammatory host response and the
associated severe lung pathology observed in DBA/2J mice in this
studyareverysimilartotheresponsetoinfectionofresistantBALB/
c and C57BL/6J mice with highly pathogenic viruses. Strongly
elevated levels of cytokines and chemokines have been found in
infections with the highly pathogenic H5N1 avian influenza virus
and with the 1918 virus of the Spanish flu compared to infections
with less virulent virus subtypes [14,15,52]. In addition viral loads
were higher in mice infected with highly pathogenic viruses [52],
findings that correlate with those in human patients [5]. Based on
these observations, it has been hypothesized that highly pathogenic
avian viruses cause a ‘‘cytokine storm’’ which results in detrimental
immune responses, although this has recently been questioned in
connection with H5N1 virus [53].
Several single gene loci have been studied in mouse knock-out
or natural mutants in the context of influenza infections. Mx1 is
mutated in most laboratory strains but fully functional in several
wild-derived mice [54–57]. Mx1 represents the major effector of
the interferon response by inhibiting viral replication [54]. The
mouse strains used in our study all carry a mutated Mx1 allele
[55], except for FVB for which the status has currently not been
characterized. Since both DBA/2J and C57BL/6J mice are
deficient for Mx1, yet DBA/2J is highly susceptible, we
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influenza virus may be due to differences in pathways that are not
downstream of the interferon response.
Our findings now provide a basis for the mapping of additional
genomic regions underlying host susceptibility to influenza
infections. F1 hybrids from a cross between DBA/2J and
C57BL/6J exhibited an intermediate weight loss phenotype and
were resistant at a dose of 2610
3. We thus speculate that the
susceptibility to influenza infection is a polygenic trait. We have
initiated F2-backcrosses and an analysis of the BXD recombinant
inbred strain set (generated from the parental strains DBA/2J and
C57BL/6J; [58,59]) to further narrow down the genomic regions
responsible for the high susceptibility in DBA/2J mice.
In conclusion, both the continuously high viral load and the
hyper-reactive inflammatory response appear to be the main
causes for the high susceptibility and lethal outcome in DBA/2J
mice after influenza A infections. DBA/2J mice exhibited an
enhanced immune response which was similar to a host infected
with a highly virulent 1918-H1N1 or H5N1 influenza virus [5,17].
We thus expect that further studies aimed at unraveling the
differential host responses in inbred mouse strains at the cellular,
genetic and molecular level will not only allow identification of
critical genomic regions of susceptibility but also contribute to a
better understanding of the pathology associated with infections
with high pathogenic influenza A virus subtypes.
Materials and Methods
Virus, mouse strains and infections
Mouse-adapted virus strains, influenza A/Puerto Rico/8/34
(H1N1; PR8) and influenza A/Seal/Massachussetts/1/80 (H7N7;
SC35M), were propagated in the chorio-allantoic cavity of 10-day-
old embryonated hen eggs for 48 hours at 37uC. Inbred mouse
strains C57BL/6J, DBA/2J, FVB/NJ, CBA/J, BALB/cByJ, and
(C57BL/6J6DBA/2J) F1 were obtained from Janvier, France,
SJL/JOrlCrl from Charles River, Germany; DBA/2NHsd from
Harlan, Germany, and A/JOlaHsD (A/J) from Harlan, U.K.
Mice were maintained under specific pathogen free conditions and
according to the German animal welfare law. All experiments
were approved by an external committee according to the German
regulations on animal welfare. For infection experiments, mice
were anesthetized by intra-peritoneal injection with Ketamin-
Rompun with doses adjusted to the individual body weight. Virus
was administered intra-nasally in a total volume of 20 ml sterile
PBS. Weight loss and survival of infected mice was followed over a
period of 14 days. In addition to mice that were found dead, mice
with a weight loss of more than 25% of the starting bodyweight
were euthanized and recorded as dead.
Extraction of RNA and real-time PCR
Total RNA was prepared from lungs using the RNeasy Midi kit
(Qiagen, Hilden, Germany) following the manufacturer’s protocol.
Quality and quantity check was performed by using Agilent 2100
bioanalyzer. For determination of viral load, reverse transcription
was carried out according to the manufacturer’s instructions using
the ThermoScript
TM RT-PCR kit (Invitrogen, Carlsbad, USA).
Briefly, 500 ng lung-extracted RNA and random hexamer primers
(Invitrogen) were mixed and denatured at 70uC for 8 min,
followed by reverse transcription at 60uC for 1 h. Reactions were
terminated by incubating the mixture at 85uC for 5 min and
RNase H treatment at 37uC for 20 min. Samples were diluted to a
final volume 50 ml and stored at 220uC. 5 ml of cDNA product
were amplified with specific primers. For HA analysis, the
following primers were used: HA01 (59 CCAGAATATACACC-
CAGTCACAAT 39) and HA02 (59 GATCCGCTGCA-
TAGCCTGAT 39). For the external standard curve, serial
dilutions (between 10
10 and 10
2 molecules) of in vitro transcribed
pGEM-T Easy-HA RNA were used. For determination of
cytokine expression, RNA was reversely transcribed with a
SuperScriptII reverse transcriptase kit (Invitrogen) according to
the manufacturer’s protocol. 500 ng lung-extracted RNAs and
random hexamers (Invitrogen) were mixed and denatured at 70uC
for 10 minutes, followed by reverse transcription at 42u for 1 h.
For cytokines and chemokines analyses the following primers were
used: Rps9 (59 CTGGACGAGGGCAAGATGAAGC, 39
TGACGTTGGCGGATGAGCACA), Il-6 (59 TAACAAGAAA-
GACAAAGCCAGAGT, 39 TTGGAAATTGGGGTAGGAA-
AG), Cxcl10 (59 CTCTCCATCACTCCCCTTTACCC, 39
GCTTCGGCAGTTACTTTTGTCTCA), Il-1 b (59 ACTA-
CAGGCTCCGAGATGAACAAC, 39 CCCAAGGCCACAGG-
TATTTT), Mip-1a (59 CTCCCAGCCAGGTGTCATTTTC, 39
CTCAGGCATTCAGTTCCAGGTCAG), Ccl2 (59 CATG-
CTTCTGGGCCTGCTGTT, 39 CCTGCTGCTGGTGATCC-
TCTTGTA). Real-time PCR was carried out with the DNA
Master SYBR Green I kit (Roche, Mannheim, Germany) using a
LightCycler 480 apparatus (Multiwell Plate 96, Roche). The
housekeeping ribosomal protein S9 (Rps9) gene was used for
normalization.
Virus titration by foci assay
MDCK II cells (American Type Culture Collection, Manassas,
USA) were cultured at 37uCi n5 %C O 2 in Dulbecco’s Modified
Eagle Medium (DMEM), supplemented with 10% fetal calf serum
(FCS), 1% penicillin/streptomycin. 1610
5 cells were seeded in 96-
well culture plates and incubated at 37uCi n5 %C O 2 for 24 h. For
foci assay, lungs of mice were homogenized in phosphate buffered
saline (PBS) with 0.1% BSA using the PolyTron 2100 homoge-
nizer. Debris was removed by centrifugation for 10 min at
1000 rpm. The samples were aliquoted and stored at 270uC.
Serial 10-fold dilutions of lung homogenates in DMEM containing
0.1% BSA were prepared and added to MDCK II cells. After 1 h,
cells were washed twice with PBS and fixed with 4% formalin in
PBS (100 ml/well). The plates were incubated at 37uCi n5 %C O 2
for 1 h. The inoculates were aspirated and replaced with 100 mlo f
1% Avicell overlay and incubated at 37uC for 24 h. Subsequently,
the plates were washed twice with PBS and fixed with 4% formalin
in PBS for 10 min at room temperature. The formalin was
removed and the cells were washed and incubated for 10 min with
100 ml/well Quencher (0.5% Triton 6100, 20 mM glycine in
PBS). After 10 min the cells were washed with Wash Buffer (0,5%
Tween 20 in PBS) and blocked with 50 ml Blocking Buffer (0.5%
Tween 20, 1% BSA in PBS) at 37uCi n5 %C O 2 for 30 min. The
primary antibody (anti-influenza Nucleocapsid NP polyclonal goat
antibody from Virostat, Portland, USA) and the secondary
antibody (anti-goat-HRP from KPL, Gaithersburg MD, USA)
were diluted 1:1000 in Blocking Buffer. 50 ml of the primary
antibody were added to each well and incubated at room
temperature for 1 h. After 1 h, the cells were washed three times
with Wash Buffer, incubated with 50 ml of the secondary antibody
for 45 min, washed again and incubated with 50 ml of substrate
(True Blue from KPL) until the blue spots from infected cell foci
appeared. Foci were counted and viral titers were calculated as
focus forming units (FFU/lung).
Cytokine and chemokine analysis
Mice were euthanized with CO2. A sterile, 22-gauge catheter
was inserted into the exposed tracheal lumen. Broncho-alveolar
lavage fluid was collected from two 0.5 ml instillations of PBS
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220uC. Cytokine and chemokine levels were analyzed using the
multi-plex cytokine analysis kit from Biosource (Carlsbad, USA)
following the manufacturer’s instructions. The plates were read on
a Luminex 100
TM instrument. MIP-2 and IL-10 (Biorad,
Hercules, CA, USA) and G-CSF and RANTES (Invitrogen) were
analyzed separately in quadruplet following the manufacturer’s
instructions.
Histological analyses
Mice were euthanized with CO2. Lungs were prepared and
immersion-fixed for 24 h in 4% buffered formaldehyde solution
(pH 7.4), dehydrated in a series of graded alcohols and embedded
in paraffin. Sections (3 mm) were cut from three evenly distributed
levels of the paraffin blocks and stained with hematoxylin and
eosin. Histological sections were examined and graded by two
pathologists in a blind fashion.
Statistical test
Means6SEM were calculated and the data for percent body
weights, viral titers, and cytokines/chemokines data were
evaluated for statistical significant differences by the non-
parametric Mann-Whitney-U-test using GraphPad Prism version
5.00 for Windows (GraphPad Software, San Diego, California;
www.graphpad.com). p values of #0.05 were considered signifi-
cant.
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